IR Library | Astellas

Investor Relations Library

IR Calendar

Upcoming events

Event

Astellas Corporate Strategic Plan Online Meeting

May 26, 2026, 4:00 p.m.- 5:30 p.m. (JST)

Event

Astellas Corporate Strategic Plan Online Meeting

May 26, 2026, 4:00 p.m.- 5:30 p.m. (JST)

Event

Astellas Corporate Strategic Plan Online Meeting

May 26, 2026, 4:00 p.m.- 5:30 p.m. (JST)

FY2025

Financial Results

Full Year and Q4/2025 Financial Results

Q3/FY2025 Financial Results

Q2/FY2025 Financial Results

Q1/FY2025 Financial Results

Integrated Report

Integrated Report 2025 (pdf 7.4MB)

IR Meetings

Astellas R&D Day (March 31, 2026)

Presentation Material (3.7MB)

On-demand Replay of Information Meeting

Meeting Script (5.2MB)

Sustainability Meeting 2025 (February 26, 2026)

Presentation Material (1.3MB)

On-demand Replay of Information Meeting

Meeting Script (3.5MB)

44th Annual J.P. Morgan Healthcare Conference
(January 12, 2026, 3:00 p.m. - 3:40 p.m. PST)

Presentation Material (3.9MB)

Meeting Script (2.8MB)

Exchange of Views with Outside Directors (December 9, 2025)

Presentation Material (680KB)

Meeting Script (1.7MB)

On-demand Replay of Information Meeting (Original audio)

Astellas Oncology Pipeline Online Meeting (October 24, 2025)

Presentation Material (7.1MB)

IZERVAY Online Meeting (July 10, 2025)

Presentation Material (4.9MB)

Shareholder Meeting

The 20th term Annual Shareholders Meeting (June 19, 2025)

Notice of Convocation of the 20th Term Annual Shareholders Meeting (revised) (pdf 3.1MB）

Notice of Resolution (pdf 146KB)

Results of the Exercise of Voting Rights (pdf 186KB)

Amendment Report for Results of the Exercise of Voting Rights (pdf 236KB)

Questions and answers from shareholders (pdf 235KB)

Annual Shareholders Meeting Script (549KB)

Information for Shareholders (Japanese only)

Summary of Consolidated Results for the Six Months Ended March 31, 2026 (Japanese) (1.0MB)

FY2024

Financial Results

Full Year and Q4/FY2024 Financial Results

Q3/FY2024 Financial Results

Q2/FY2024 Financial Results

Q1/FY2024 Financial Results

Integrated Report

Integrated Report 2024

IR Meetings

Sustainability Meeting 2024 , February 21, 2025

Presentation Material (2.1MB)

On-demand Replay of Information Meeting

Meeting Script (5.0MB)

ASP3082/Targeted Protein Degradation Online Meeting, September 27, 2024

Presentation Material (1.7MB)

On-demand Replay of Information Meeting

Meeting Script (2.8MB)

Shareholder Meeting

The 19th term Annual Shareholders Meeting, June 20, 2024

Notice of Convocation of the 19th Term Annual Shareholders Meeting (pdf 2.9MB)

Notice of Resolution (pdf 145KB)

Results of the Exercise of Voting Rights (176KB)

Questions and answers from shareholders (pdf 161KB)

Annual Shareholders Meeting Script (454KB)

FY2023

Financial Results

Full Year and Q4/FY2023 Financial Results

Q3/FY2023 Financial Results

Q2/FY2023 Financial Results

Q1/FY2023 Financial Results

Integrated Report

Integrated Report 2023

IR Meetings

VYLOY (zolbetuximab) Online Meeting , March 29, 2024

Presentation Material (2.9MB)

Sustainability Meeting 2023, February 21, 2024

Presentation Material (3.4MB)

On-demand Replay of Information Meeting

Meeting Script (3.8MB)

IZERVAY Online Meeting , November 6, 2023

Presentation Material (784KB)

On-demand Replay of Information Meeting

Meeting Script (2.6MB)

VEOZAH (fezolinetant) Online Meeting, May 19, 2023

Presentation Material (3.9MB)

Patient & HCP Perspectives (video)

Astellas Online Meeting (Acquisition of Iveric Bio), May 1, 2023

Presentation Material (824MB)

On-demand Replay of Information Meeting

Meeting Script

Shareholder Meeting

The 18th term Annual Shareholders Meeting, June 22, 2023

Notice of Convocation of the 18th Term Annual Shareholders Meeting (pdf 2.8MB)

Notice of Resolution (pdf 143KB)

Results of the Exercise of Voting Rights (pdf 185KB)

Questions and answers from shareholders (pdf 112KB)

Annual Shareholders Meeting script (pdf 489KB)

FY2022

Financial Results

Full Year and Q4/FY2022 Financial Results

Q3/FY2022 Financial Results

Q2/FY2022 Financial Results

Q1/FY2022 Financial Results

Integrated Report

Integrated Report 2022

IR Meetings

Sustainability Meeting 2022, February 17, 2023

Presentation Material (1,712KB)

On-demand Replay of Information Meeting

Meeting Script (4,476KB)

IR Meeting for Individual Investors (Hosted by Rakuten Securities, Inc.), December 14, 2022

Presentation Material (Eng. Translation) (1,566KB)

R&D Meeting, December 9, 2022

Targeted Protein Degradation (734KB)

On-demand Replay of Information Meeting

Meeting Script (2,607KB)

Shareholder Meeting

The 17th term Annual Shareholders Meeting, June 20, 2022

Notice of Convocation of the 17th Term Annual Shareholders Meeting (pdf 1.9MB)

Notice of Resolution (pdf 120KB)

Results of the Exercise of Voting Rights (pdf 67KB)

Questions and answers from shareholders (pdf 137KB)

Annual Shareholders Meeting script (pdf 499KB)

Other

Media Briefing, March 27, 2023

Astellas’ Corporate-wide Digital Transformation Driven by Analytics (888KB)

On-demand Replay of Information Meeting

Meeting Script (3,278KB)

FY2021

Financial Results

Full Year and Q4/FY2021 Financial Results

Q3/FY2021 Financial Results

Q2/FY2021 Financial Results

Q1/FY2021 Financial Results

Integrated Report

Integrated Report 2021

IR Meetings

R&D Meeting, March 9, 2022

Initiatives for Gene Therapy (2,933KB)

Meeting Script (8,030KB)

Sustainability Meeting 2021, February 28, 2022

Presentation Material (946KB)

Meeting Script (4,467KB)

R&D Meeting, December 7, 2021

NEW RESEARCH ORGANIZATION STRUCTURE (1,245KB)

Meeting Script (2,654KB)

Corporate Strategic Plan 2021, May 26, 2021

CSP2021 (1,096KB)

Shareholder Meeting

The 16th term Annual Shareholders Meeting, June 18, 2021

Notice of Convocation of the 16th Term Annual Shareholders Meeting (pdf 1.6MB)

Notice of Resolution (pdf 77KB)

Results of the Exercise of Voting Rights (pdf 83KB)

Other

Media Briefing, January 21, 2022

Digital Transformation of Astellas Pharma (3,351KB)

On-demand Replay of Information Meeting

Meeting Script (3,989KB)

FY2020

Financial Results

Full Year and Q4/FY2020 Financial Results

Q3/FY2020 Financial Results

Q2/FY2020 Financial Results

Q1/FY2020 Financial Results

Integrated Report

Annual Report 2020

GRI Content Index

IR Meetings

R&D Meeting, December 10, 2020

PROGRESS IN FOCUS AREA APPROACH (5,333KB)

FY2019

Financial Results

Full Year and Q4/FY2019 Financial Results

Q3/FY2019 Financial Results

Q2/FY2019 Financial Results

Q1/FY2019 Financial Results

Integrated Report

Annual Report 2019 (3,544KB)

GRI Content Index (160KB)

IR Meetings

R&D Meeting, December 10, 2019

Initiatives in immuno-oncology (3,894KB)

Conference Call (Acquisition of Audentes), December 3, 2019

Conference Call: Acquisition of Audentes (960KB)

Enfortumab vedotin Investor Meeting, October 1, 2019

Conference Call: enfortumab vedotin (1,235KB)

FY2018

Financial Results

Full Year and Q4/FY2018 Financial Results

Q3/FY2018 Financial Results

Q2/FY2018 Financial Results

Q1/FY2018 Financial Results

Integrated Report

Annual Report 2018 (2,790KB)

GRI Content Index (121KB)

IR Meetings

Hosted by securities companies, January 8, 2019

J.P. Morgan Healthcare Conference (January 8, 2019 in local time) (733KB)

R&D Meeting, December 13, 2018

INITIATIVES IN CELL THERAPY (3,229KB)

Corporate Strategic Plan 2018, May 22, 2018

Strategic Plan 2018 (1,044KB)

FY2017

Financial Results

Full Year and Q4/FY2017 Financial Results

Q3/FY2017 Financial Results

Q2/FY2017 Financial Results

Q1/FY2017 Financial Results

Integrated Report

Annual Report 2017 (3,647KB)

GRI Content Index (119KB)

IR Meetings

Fezolinetant Investor Meeting, December 14, 2017

fezolinetant: A Novel Approach for Targeted Menopausal Symptom Relief (1,946KB)

Choose Language

Investor Relations Library

IR Calendar

Astellas Corporate Strategic Plan Online Meeting

Astellas Corporate Strategic Plan Online Meeting

Astellas Corporate Strategic Plan Online Meeting

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017